Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORM-12741 fMRI study in healthy volunteers
NCT03440021Phase 1Completed
- Sponsor
- University of Cape Town
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ORM-12741 in Alzheimer's disease (AD) (3 arms), sponsored by University of Cape Town. Primary endpoints: Effect of ORM-12741 on BOLD signal in fMRI of the brain areas associated with emotional memory and Effect of ORM-12741 on BOLD signal in fMRI of the brain areas associated with working memory. Started Mar 2018; status: completed.
02
Drugs
ORM-12741
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03440021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03440021.